A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy
- 1 July 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 10 (5) , 439-451
- https://doi.org/10.1097/00008571-200007000-00007
Abstract
We have previously shown that primary trimethylaminuria, or fish-odour syndrome, is caused by an inherited defect in the flavin-containing monooxygenase 3 (FMO3) catalysed N-oxidation of the dietary-derived malodorous amine, trimethylamine (TMA). We now report a novel causative mutation for the disorder identified in a young girl diagnosed by proton nuclear magnetic resonance (NMR) spectroscopy of her urine. Sequence analysis of genomic DNA amplified from the patient revealed that she was homozygous for a T to C missense mutation in exon 3 of the FMO3 gene. The mutation changes an ATG triplet, encoding methionine, at codon 82 to an ACG triplet, encoding threonine. A polymerase chain reaction/restriction enzyme-based assay was devised to genotype individuals for the FMO3Thr82 allele. Wild-type and mutant FMO3, heterologously expressed in a baculovirus-insect cell system, were assayed by ultraviolet spectrophotometry and NMR spectroscopy for their ability to catalyse the N-oxidation of TMA. The latter technique has the advantage of enabling the simultaneous, direct and semi-continuous measurement of both of the products, TMA N-oxide and NADP, and of one of the reactants, NADPH. Results obtained from both techniques demonstrate that the Met82Thr mutation abolishes the catalytic activity of the enzyme and thus represents the genetic basis of the disorder in this individual. The combination of NMR spectroscopy with gene sequence and expression technology provides a powerful means of determining genotype-phenotype relationships in trimethylaminuria.Keywords
This publication has 35 references indexed in Scilit:
- Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditionsPublished by Elsevier ,2004
- Structural Organization of the Human Flavin-Containing Monooxygenase 3 Gene (FMO3), the Favored Candidate for Fish-Odor Syndrome, Determined Directly from Genomic DNAGenomics, 1997
- Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4European Journal of Biochemistry, 1996
- Diagnosis of a new case of trimethylaminuria using direct proton NMR spectroscopy of urineJournal of Inherited Metabolic Disease, 1995
- The fish odour syndrome: biochemical, familial, and clinical aspects.BMJ, 1993
- Trimethylaminuria (‘fish-odour syndrome’): A study of an affected familyClinical Science, 1988
- Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approachClinical Pharmacology & Therapeutics, 1987
- A Genetic polymorphism of the N-oxidation of trimethylamine in humansClinical Pharmacology & Therapeutics, 1987
- TRIMETHYLAMINURIA (FISH-ODOUR SYNDROME): AN INBORN ERROR OF OXIDATIVE METABOLISMThe Lancet, 1987
- The metabolism of14C-labelled trimethylamine and itsN-oxide in manXenobiotica, 1987